Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01118416 · ClinicalTrials.gov registry record · NA

Risk Reduction Intervention for Vulnerable Young Adult Males

A NA study of HIV and Substance Use, sponsored by Hunter College of City University of New York.

Completed
Registry status
NA
Development phase
317
Enrollment target
1
Study location

NCT01118416 is a NA study of HIV and Substance Use that has completed, run by Hunter College of City University of New York. The registered enrollment target is 317 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01118416, a NA study of HIV and Substance Use, has completed, sponsored by Hunter College of City University of New York.

COMPLETED
Registry status
NA
Development phase
317 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this study is to test a brief 4-session risk reduction intervention, based on Motivational Enhancement Therapy (MET) to reduce the co-occurrence of club drug use and sexual risk taking behaviors among non-treatment seeking young men who have sex with men (YMSM) in NYC.

Conditions Studied

Interventions

  • BEHAVIORAL HIV prevention intervention randomized control trial

Study Locations (1)

New York

  • Center for HIV/AIDS Educational Studies and Training of Hunter College, CUNY - New York

Trial Details

FieldValue
Enrollment Target 317 participants
Start Date 2006-06
Est. Completion 2011-10
Phase NA

What the Registry Record Tells You About NCT01118416

The ClinicalTrials.gov registry entry for NCT01118416 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 317 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (28% lower). The listed sponsor is Hunter College of City University of New York, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which HIV prevention intervention randomized control trial is the first listed.

NCT01118416 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01118416 about?

NCT01118416 is a clinical study titled "Risk Reduction Intervention for Vulnerable Young Adult Males". The primary aim of this study is to test a brief 4-session risk reduction intervention, based on Motivational Enhancement Therapy (MET) to reduce the co-occurrence of club drug use and sexual risk taking behaviors among non-treatment seeking young men who have sex with men (YMSM) in NYC.

What is the current status of trial NCT01118416?

This trial is currently completed. It is a NA study. The enrollment target is 317 participants. The study started on 2006-06. Estimated completion is 2011-10.

What conditions does trial NCT01118416 study?

This clinical trial studies the following conditions: HIV, Substance Use, Sex.

What interventions are being tested in trial NCT01118416?

The interventions under investigation include: HIV prevention intervention randomized control trial (BEHAVIORAL).

Who is sponsoring clinical trial NCT01118416?

This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01118416 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.